| Genetic identification of familial hypercholesterolemia within a single US health care system NS Abul-Husn, K Manickam, LK Jones, EA Wright, DN Hartzel, ... Science 354 (6319), aaf7000, 2016 | 419 | 2016 |
| Clinical outcomes of a genomic screening program for actionable genetic conditions AH Buchanan, HL Kirchner, MLB Schwartz, MA Kelly, T Schmidlen, ... Genetics in Medicine 22 (11), 1874-1882, 2020 | 100 | 2020 |
| Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association JG Robinson, MB Jayanna, AS Brown, K Aspry, C Orringer, EA Gill, ... Journal of clinical lipidology 13 (4), 525-537, 2019 | 55 | 2019 |
| International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia GF Watts, SS Gidding, RA Hegele, FJ Raal, AC Sturm, LK Jones, ... Nature Reviews Cardiology 20 (12), 845-869, 2023 | 54 | 2023 |
| Improving clinical practice guidelines with implementation science MN Sarkies, LK Jones, SS Gidding, GF Watts Nature Reviews Cardiology 19 (1), 3-4, 2022 | 35 | 2022 |
| Medication therapy disease management: Geisinger’s approach to population health management LK Jones, G Greskovic, DM Grassi, J Graham, H Sun, MR Gionfriddo, ... American journal of health-system pharmacy 74 (18), 1422-1435, 2017 | 33 | 2017 |
| Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association BA Warden, JR Guyton, AC Kovacs, JA Durham, LK Jones, DL Dixon, ... Journal of clinical lipidology 17 (1), 19-39, 2023 | 30 | 2023 |
| Healthcare utilization and patients’ perspectives after receiving a positive genetic test for familial hypercholesterolemia: a pilot study LK Jones, A Kulchak Rahm, K Manickam, L Butry, A Lazzeri, T Corcoran, ... Circulation: Genomic and Precision Medicine 11 (8), e002146, 2018 | 27 | 2018 |
| Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis LK Jones, S Tilberry, C Gregor, LH Yaeger, Y Hu, AC Sturm, TL Seaton, ... Implementation Science 16, 1-15, 2021 | 26 | 2021 |
| Developing and optimizing innovative tools to address familial hypercholesterolemia underdiagnosis: identification methods, patient activation, and cascade testing for familial … G Campbell-Salome, LK Jones, MF Masnick, NA Walton, CD Ahmed, ... circulation: genomic and precision medicine 14 (1), e003120, 2021 | 26 | 2021 |
| Barriers, facilitators, and solutions to familial hypercholesterolemia treatment LK Jones, AC Sturm, TL Seaton, C Gregor, SS Gidding, MS Williams, ... PLoS One 15 (12), e0244193, 2020 | 26 | 2020 |
| Developing pharmacogenomic reports: insights from patients and clinicians LK Jones, A Kulchak Rahm, MR Gionfriddo, JL Williams, AL Fan, RA Pulk, ... Clinical and Translational Science 11 (3), 289-295, 2018 | 25 | 2018 |
| Hidden Burden of Electronic Health Record‐Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care P Patel, Y Hu, A Kolinovsky, Z Geng, J Ruhl, S Krishnamurthy, ... Journal of the American Heart Association 8 (13), e011822, 2019 | 20 | 2019 |
| Population genomic screening for three common hereditary conditions: a cost-effectiveness analysis GF Guzauskas, S Garbett, Z Zhou, JS Schildcrout, JA Graves, MS Williams, ... Annals of Internal Medicine 176 (5), 585-595, 2023 | 19 | 2023 |
| The importance of buprenorphine research in the opioid crisis SA Pendergrass, RC Crist, LK Jones, JR Hoch, WH Berrettini Molecular Psychiatry 24 (5), 626-632, 2019 | 17 | 2019 |
| Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis LK Jones, M McMinn, D Kann, M Lesko, AC Sturm, N Walters, N Chen, ... Implementation Science Communications 2, 1-10, 2021 | 16 | 2021 |
| Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States SJ Spencer, LK Jones, GF Guzauskas, J Hao, MS Williams, JF Peterson, ... Journal of clinical lipidology 16 (5), 667-675, 2022 | 15 | 2022 |
| Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: a protocol LK Jones, SS Gidding, TL Seaton, A Goldberg, C Gregor, AC Sturm, ... Research in Social and Administrative Pharmacy 16 (3), 390-395, 2020 | 13 | 2020 |
| Generation and implementation of a patient-centered and patient-facing genomic test report in the EHR JM Goehringer, MA Bonhag, LK Jones, T Schmidlen, M Schwartz, ... eGEMs 6 (1), 2018 | 13 | 2018 |
| A RE-AIM framework analysis of DNA-based population screening: using implementation science to translate research into practice in a healthcare system LK Jones, NT Strande, EM Calvo, J Chen, G Rodriguez, CZ McCormick, ... Frontiers in Genetics 13, 883073, 2022 | 12 | 2022 |
Marc S. WilliamsProfessor and Director Emeritus, Genomic Medicine Institute, GeisingerVerified email at geisinger.edu
